157 completed, 10 unknown, 6 active not recruiting, 5 not yet recruiting. 188 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 188 | Completed 157, Unknown 10, Active not recruiting 6, Not yet recruiting 5, Recruiting 5, Terminated 3, Withdrawn 2 |
| Phase 2 | 4 | Unknown 3, Completed 1 |
Follow Rosuvastatin: new trials by email Literature Review of Rosuvastatin trials Research Report on Rosuvastatin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial of MK-6916 With Midazolam and Rosuvastatin in Healthy Participants (MK-6916-012) Midazolam, Rosuvastatin, MK-6916 - Healthy | Phase 1 | Not yet recruiting | Merck Sharp & Dohme LLC | 18 | 2026-11-30 | 2026-10-07 |
| A Study in Healthy Male Participants to Compare How CHF10196 Affects How the Body Absorbs and Processes Two Commonly Used Medicines: Dabigatran, a Blood Thinner, and Rosuvastatin, a Medicine Used to Lower Cholesterol Dabigatran Etexilate, Rosuvastatin, CHF10196 - Healthy Male Volunteers | Phase 1 | Not yet recruiting | Chiesi Farmaceutici S.p.A. | 24 | 2026-10-27 | 2026-08-04 |
| An Open-label DDI Study to Investigate the Effect of Rilzabrutinib on P-gp, BCRP, OATP1B1 and OATP1B3 Inhibition Rilzabrutinib, Rosuvastatin, Digoxin - Healthy Volunteer | Phase 1 | Active not recruiting | Sanofi | 14 | 2026-10-01 | 2026-10-21 |
| A Trial in Healthy Participants to Assess Drug Interaction Potential of BGB-43395 BGB-43395, Midazolam, Celecoxib - Healthy Adult Participants | Phase 1 | Recruiting | BeOne Medicines | 24 | 2026-09-25 | 2026-10-23 |
| A Clinical Trial to Evaluate the Effects of MK-4646 on Rosuvastatin in Healthy Participants (MK-4646-007) Rosuvastatin, MK-4646 - Healthy | Phase 1 | Not yet recruiting | Merck Sharp & Dohme LLC | 16 | 2026-09-25 | 2026-10-05 |
| A Phase I Study of the Interaction of D-2570 With Other Drugs in Healthy Adults Itraconazole, Rifampicin, Omeprazole - Healthy Subjects | Phase 1 | Not yet recruiting | InventisBio Co., Ltd | 60 | 2026-09-16 | 2026-10-15 |
| Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants BMS-986533, Famotidine, Placebo - Healthy Volunteers | Phase 1 | Recruiting | Bristol-Myers Squibb | 136 | 2026-07-13 | 2026-07-24 |
| A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants Elecoglipron, Atorvastatin, Rosuvastatin - Healthy Participants | Phase 1 | Active not recruiting | AstraZeneca | 48 | 2026-04-16 | 2026-08-28 |
| A Study to Learn More About How Safe Nurandociguat is and How it Affects the Way the Body Processes Rosuvastatin and Dabigatran in Healthy Adults Nurandociguat, Rosuvastatin, Dabigatran etexilate - Chronic Kidney Disease | Phase 1 | Withdrawn | Bayer | 2026-04-08 | 2026-05-12 | |
| A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together Repinatrabit, EE/NE, Metformin - Healthy Volunteers | Phase 1 | Recruiting | Otsuka Pharmaceutical Development & Commercialization, Inc. | 48 | 2026-03-31 | 2026-08-12 |
| A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005) Rosuvastatin, Furosemide, MK-2828 - Healthy | Phase 1 | Completed | Merck Sharp & Dohme LLC | 41 | 2026-03-18 | 2026-09-08 |
| Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers Simvastatin (10mg, 20mg, 40mg), Rosuvastatin (5mg, 20mg, 40mg), Atorvastatin (10mg, 20mg, 40mg) - Diabete Mellitus, Lipid Profile | Phase 1 | Not yet recruiting | Shaheed Benazir Bhutto University Sheringal Dir Upper | 100 | 2026-03-01 | 2026-01-30 |
| A Study of LY4515100 in Healthy Participants LY4515100 via SAD, LY4515100 via MAD, LY4515100 - Healthy | Phase 1 | Recruiting | Eli Lilly and Company | 123 | 2026-01-15 | 2026-07-29 |
| Effect of Vanzacaftor/Tezacaftor/Deutivacaftor (VNZ/TEZ/D-IVA) on the PK of Rosuvastatin in Healthy Participants VNZ/TEZ/D-IVA, Rosuvastatin - Cystic Fibrosis | Phase 1 | Completed | Vertex Pharmaceuticals Incorporated | 18 | 2026-01-12 | 2026-04-02 |
| Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants Repotrectinib, Metformin, Digoxin - Healthy Volunteers | Phase 1 | Completed | Bristol-Myers Squibb | 30 | 2025-12-31 | 2026-03-27 |
| A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039) MK-0616A, Enlicitide, Rosuvastatin - Healthy | Phase 1 | Active not recruiting | Merck Sharp & Dohme LLC | 60 | 2025-12-29 | 2026-09-23 |
| A Clinical Study of Calderasib (MK-1084) With Rosuvastatin and Metformin in Healthy People (MK-1084-016) Rosuvastatin, Metformin, Calderasib - Healthy | Phase 1 | Completed | Merck Sharp & Dohme LLC | 16 | 2025-11-19 | 2026-05-06 |
| A Study in Healthy People to Test Whether BI 3000202 Affects How 2 Other Medicines (Rosuvastatin and Digoxin) Are Taken up in the Body BI 3000202, Rosuvastatin, Digoxin - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 14 | 2025-11-05 | 2025-12-22 |
| Evaluate the Effect of Vimseltinib on the Pharmacokinetics of a BCRP and OATP1B1 Substrate Vimseltinib, Rosuvastatin - Healthy Participants | Phase 1 | Completed | Deciphera Pharmaceuticals, LLC | 20 | 2025-10-31 | 2026-01-15 |
| Evaluating Bioequivalence of a Fixed Dose Combination Versus Tablets of Bempedoic Acid / Ezetimibe and Rosuvastatin Bempedoic acid, Ezetimibe, Rosuvastatin - Healthy Subjects | Phase 1 | Completed | Daiichi Sankyo | 58 | 2025-10-07 | 2025-12-18 |
Showing 20 of 188. Sign in to see all of them.
Hypertension (9) · Obesity (7) · Diabetes Mellitus, Type 2 (6) · Dyslipidemias (6) · Hyperlipidemias (5) · Hypercholesterolemia (4) · Overweight (4) · Diabetes Mellitus (3) · Neoplasms (3) · Acute Coronary Syndrome (2) · Arthritis, Rheumatoid (2) · Breast Neoplasms (2) · COVID-19 (2) · HIV Infections (2) · Hepatitis C (2)
AstraZeneca (18) · Boehringer Ingelheim (11) · Pfizer (11) · Bristol-Myers Squibb (10) · Eli Lilly and Company (8) · Alvogen Korea (6) · Bayer (6) · Merck Sharp & Dohme LLC (6) · Boryung Pharmaceutical Co., Ltd (5) · Enanta Pharmaceuticals, Inc (4) · GlaxoSmithKline (4) · University of California, San Francisco (4) · Alexion Pharmaceuticals, Inc. (3) · Celgene (3) · Daiichi Sankyo (3)
United States (89) · Germany (20) · South Korea (16) · United Kingdom (16) · China (11) · Belgium (7) · Spain (5) · Canada (4) · Czechia (4) · Japan (4) · Netherlands (4) · Moldova (3) · Australia (2) · France (2) · Hungary (2)
PMID 15324521, PMID 22288567, PMID 23289819, PMID 27878567, PMID 28385543, PMID 28685495, PMID 30171779, PMID 31321631, PMID 33704925, PMID 33782832, PMID 34370076, PMID 34477937, PMID 34866168, PMID 35118821, PMID 35344588, PMID 36376130, PMID 37858005, PMID 38424308, PMID 38878209, PMID 40291342, PMID 41058119, PMID 41246975, PMID 42023995, PMID 42053447, PMID 42062754, PMID 42137960
2019 (6), 2015 (4), 2014 (1), 2016 (1), 2017 (1), 2018 (1), 2023 (1), 2025 (1)